Circulating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: a preliminary study

Sci Rep. 2017 Jan 11:7:40530. doi: 10.1038/srep40530.

Abstract

This study aimed to investigate the less known activation pattern of T lymphocyte populations and immune checkpoint inhibitors on immunocytes in patients with bipolar II disorder depression (BD) or major depression (MD). A total of 23 patients with BD, 22 patients with MD, and 20 healthy controls (HCs) were recruited. The blood cell count of T lymphocyte subsets and the plasma level of cytokines (IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ) were selectively investigated. The expression of T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), programmed cell death protein 1 (PD-1) and its ligands, PD-L1 and PD-L2, on T lymphocytes and monocytes, was detected. In results, blood proportion of cytotoxic T cells significantly decreased in BD patients than in either MD patients or HCs. The plasma level of IL-6 increased in patients with BD and MD. The expression of TIM-3 on cytotoxic T cells significantly increased, whereas the expression of PD-L2 on monocytes significantly decreased in patients with BD than in HCs. These findings extended our knowledge of the immune dysfunction in patients with affective disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • B7-H1 Antigen / metabolism
  • Bipolar Disorder / blood*
  • Bipolar Disorder / immunology*
  • Case-Control Studies
  • Cytokines / blood*
  • Demography
  • Depressive Disorder, Major / blood*
  • Depressive Disorder, Major / immunology*
  • Female
  • Humans
  • Killer Cells, Natural / immunology
  • Lymphocyte Activation / immunology
  • Male
  • T-Lymphocyte Subsets / immunology*

Substances

  • B7-H1 Antigen
  • CD274 protein, human
  • Cytokines